The global genomic biomarker market is complex with a variety of applications in cancer diagnosis, prognosis, and targeted therapy selection. Genomic biomarkers are genetic variations detected either in DNA or RNA from blood or other clinical samples that help predict treatment response, survival, recurrence, and other clinically significant outcomes. The genomic data from next-generation...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian